Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreNew Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read more